A Pre-symptomatic phase of tumefactive multiple sclerosis mirrors radiologically isolated syndrome

Albert Aboseif1, Nur Neyal2, B Mark Keegan1

  • 1Division of Multiple Sclerosis and Autoimmune Neurology, Department of Neurology, Mayo Clinic, Rochester, MN, USA; Center for Multiple Sclerosis and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.

Abstract

Insights

A pre-symptomatic phase of tumefactive multiple sclerosis (TMS) may be underrecognized. This study found similar frequencies and symptomatic evolution in pre-symptomatic TMS compared to non-tumefactive MS (nTMS).

Area of Science:

  • Neurology
  • Neuroimmunology
  • Radiology

Background:

  • Tumefactive multiple sclerosis (TMS) presents with large demyelinating lesions and severe attacks.
  • A pre-symptomatic phase, akin to radiologically isolated syndrome (RIS) in MS, is not well-defined for TMS.

Purpose of the Study:

  • To characterize the pre-symptomatic phase of TMS.
  • To compare the frequency and symptomatic evolution of pre-symptomatic TMS with a matched cohort of non-tumefactive MS (nTMS).

Main Methods:

  • Included adults (≥18 years) with tumefactive demyelinating lesions (TDL; ≥2 cm) meeting 2024 McDonald Criteria.
  • Defined pre-symptomatic TMS as incidental TDLs meeting pre-symptomatic MS criteria.
  • Compared pre-symptomatic disease frequency and symptomatic evolution to a matched nTMS cohort using Fisher's exact test and Kaplan-Meier analysis.

Main Results:

  • Seven of 202 TMS patients (4%) had pre-symptomatic disease (median age 51 years).
  • The frequency of pre-symptomatic disease was 3.1% in TMS versus 5.4% in nTMS (p=0.54) after matching.
  • Symptomatic evolution rates were similar between pre-symptomatic TMS (25%) and nTMS (14%) cohorts (p=1.0), though event numbers were limited.

Conclusions:

  • A pre-symptomatic phase of TMS, similar to RIS, may be underrecognized.
  • Incidental tumefactive brain lesions warrant evaluation for a potential pre-symptomatic phase.
  • Larger studies are needed to clarify differences in symptomatic evolution between pre-symptomatic TMS and nTMS.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Stages of Infection01:26

Stages of Infection

Stages of infection describe what happens to a susceptible host once a pathogen invades the human body. The stages of infection are incubation, prodromal, illness, stage of decline, and convalescence. The incubation stage is the period from exposure to a pathogen until symptoms start. The infected person is unaware of impending illness as the pathogens grow and multiply within the body. The duration may vary depending on the type of infection. The incubation period of measles averages ten to...